International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014

Size: px
Start display at page:

Download "International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014"

Transcription

1 International NetCord Foundation Executive Committee Conference Call Minutes September 10, 2014 Committee Members: Staff: President Etienne Baudoux and Drs. Gesine Koegler, Joanne Kurtzberg and Alexander Platz and Vanderson Rocha Holger Gressmann, Andrea King, Robert Krawisz and Ken Luurs The meeting was called to order by President Baudoux at 8:35 a.m. CDT. I. APPROVAL OF MINUTES Approval of Minutes CONSENSUS: Approve the minutes of the Executive Committee meeting on June 18, II. REQUEST FROM INTERNATIONAL JOSE CARRERAS FOUNDATION Communication on EMDIScord CONSENSUS: Approve and send the letter submitted by Holger Gressmann to Dr. Enric Carreras at the International José Carreras Foundation which provides technical input on EMDIScord issues and clarification on unit ID listings (ways to filter out duplicates). III. NETCORD MEMBERS INVENTORY AND USE Update for NetCord Website CONSENSUS: Accept the report submitted by Holger Gressmann on NetCord member inventory and use and direct Mr. Gressmann to work with Mr. Ken Luurs to develop a user friendly schedule for posting on the NetCord Website. IV. STRATEGIC PLANNING RETREAT Draft Strategic Planning Document CONSENSUS: Approve the first draft of the Strategic Planning document developed from the retreat in Milan (enclosed Exhibit). This document was sent to NetCord Members for review and there were only three replies with no substantive changes. CONSENSUS: Request the Board of Directors to approve the final Strategic Planning document during its meeting on October 22 and to start development of goals and strategies. V. NEW MEMBER APPLICATIONS CONSENSUS: Direct staff to send new member applications from the Anthony Nolan Cord Blood Bank and the Portuguese Public Cord Blood Bank to Drs. Alexander Platz and Timothy Devos for review. Recommendations will be discussed during the October Board of Directors meeting.

2 NetCord Executive Committee September 10, 2014 Page Two VI. CREATION OF CORD BLOOD ASSOCIATION Update on Recent Activities Dr. Joanne Kurtzberg provided an update on the work being done to develop a trade and professional association for public and private Cord Blood Banks: The stated focus of the Association will be on promoting the use of cord blood, assisting in development of standards, supporting cord blood research, providing education and lobbying. Members of the Advisory Committee are Sue Armitage, Andrew Balber, Geoffrey Crouse, Ken Giacin, Joanne Kurtzberg, Alan Leahigh, Richard Lockie, Mahendra Rao, Donna Regan, Buzz Sztukowski and Frances Verter. Alan Leahigh is working with a law firm to incorporate the new association as a 501(c)6 organization with a 501(c)3 subsidiary. A call for nominations was sent out for members of the Board of Directors which will include representatives from private and public cord blood banks and additional at large members. Dr. Kurtzberg will be a member of the Board. Dr. Kurtzberg agreed to share the minutes of Advisory Committee meetings with the NetCord Executive Committee. These are also available on the Advisory Committee s LinkedIn site. The new cord blood association will solicit membership from cord blood banks globally and from individuals interested in cord blood banking and transplantation. Other industry developments include changing management of the International Cord Blood Symposium to AABB. CONSENSUS: The NetCord Executive Committee will develop recommendations on the actions NetCord should take in collaborating with this new cord blood association for discussion at the October Board of Directors meeting. VII. WMDA WMDA Fee Schedule Dr. Gesine Koegler reported that WMDA is requesting cord blood bank members pay a fee per cord blood unit shipment. She suggested that the fee schedule appeared to be onerous for smaller programs. CONSENSUS: Request Dr. Baudoux to contact Lydia Foeken, WMDA Executive Director, for an explanation of the fee schedule.

3 NetCord Executive Committee September 10, 2014 Page Three VIII. INFORMATION REPORTS The following informational reports were received: Introduction of Mr. Ken Luurs, new Managing Director Dr. Baudoux 2014 NetCord Meeting Schedule Dr. Baudoux Submitted by Eliane Gluckman By Bob Krawisz IX. ADJOURNMENT The meeting was adjourned at 9:40 a.m. CDT. Staff was requested to send out a reminder on the Board of Directors Wednesday, October 22 (GoToMeeting Conference Call).

4 EXHIBIT DRAFT NETCORD STRATEGIC PLAN Milan Board of Directors Retreat I. NetCord Mission The mission of the International NetCord Foundation is: To promote the highest quality in cord blood products through worldwide standards and accreditation. To balance global supply and demand for umbilical cord blood. To encourage and facilitate the use of cord blood transplants by promoting laboratory and clinical research and providing professional and public education. II. Strategic Questions Why Does NetCord Exist? To create opportunities for the supply and use of cord blood products. To upgrade cord blood banking and transplantation science worldwide What should be NetCord's philosophy (i.e. the focus and direction for the organization)? Establish quality norms and promote the use of cord blood transplants as standard of care globally. Gather CBBs and sustain each other through exchange of information and mutual collaborations. Cord blood transplants in hematological and non-hematological clinical indications. Who is NetCord? Principled, focused cord blood banks dedicated to the successful collection, processing and distribution of cord blood products. An international non-profit association of the most accredited cord blood banks. What does NetCord represent? The unified standards, banks and cord blood product market. High quality CBBs (accredited or in their way toward accreditation). Represents approximately 35 cord blood banks and institutes working in stem cell transplants. Whom does NetCord serve? Two audiences: the cord blood banks and the end-users. CBBs and transplantation centers. Serves cord blood grafts globally via its virtual office according specific standards (HLA, Graft Size, and Cell Count). 1

5 III. What does NetCord do as an organization? Should set forth the standards, require accreditation, and then actively promote the use of cord blood products globally. Exchange information between CBBs and gather them (together we are stronger). Interact with approximately 35 CBBs in crucial matters related to cord blood laboratory and clinical research, inspect and accredit cord blood banks according FACT standards. Values NetCord members hold in highest regard the following principles: An umbilical cord blood donation is a gift of health and well-being to a seriously ill patient. Donors should be held in high esteem, and the donation managed with great respect. Umbilical cord blood is a key component in the future of hematopoietic stem cell therapy and regenerative medicine. Its potential will be realized through basic and clinical research and greater professional and public awareness of the therapeutic value of cord blood. Cord blood has the greatest social value when donated to an accredited bank for allogeneic use and made fully accessible to all potential patients. For cord blood therapies to reach their full potential, cord blood banks must maintain high standards to assure quality products, and the process for banking, selecting and procuring stem cells must be accurate, efficient and economically sustainable. What are NetCord's Values (i.e. NetCord's core beliefs, NetCord's most deeply held convictions, the ideals that NetCord holds in the highest regard, in good times and in bad). Collect the right cords at the right time, store them in the right banks, and make them accessible to everyone. Values excels on well-being of seriously ill patients diagnosed with hematological or non-hematological diseases aided by high-quality and efficient cord blood products for the reconstitution of hematopoietic system after high dose chemoradio therapy or for regenerative purposes in degenerative diseases. IV. Vision The International NetCord Foundation and its members will be known throughout the transplant community for highly ethical practice and quality standards, and for the value of their products and services to transplant professionals and their patients. What is NetCord s Vision (i.e. a clear and compelling view of what NetCord must be in the future, a statement so clearly stated and inspiring that people will feel a strong desire to work together to arrive at this destination described in the vision)? Promote the best cord at the best time from the best bank. Vision is the global standardization and harmonization of the highest quality procedures and ethical practices in non-hematopoietic stem cell transplant community. 2

6 V. Benefits Reasons why CBB join and maintain their NetCord membership: To establish an image of credibility and quality. Exchange of information between CBBs. To increase CBB s excellence and reputation in transplant community. VI. Role Definition NetCord s role in the education of the CBB (and BMT) community? NetCord s role in developing policies for CBB? NetCord s role in the future of the CBB and BMT community? NetCord s role in the education of the Cord Blood Bank and Blood and Marrow Transplantation community? Educate on cord blood quality standards and create opportunities for continued improvement and learning. Crucial to educate scientific community related to laboratory, regulatory and transplant topics. NetCord s role in developing policies for Cord Blood Banks? Assembling best practices/policies and making them available to member banks. To develop well social impact policies related to public and private banking. NetCord s role in the future of the Cord Blood Bank and Blood and Marrow Transplantation community? Global advocate for cord blood banking and for cord blood product acceptance as a standard treatment option. More visibility of the organization is needed. To design and develop committees and working groups focus on new clinical indications in regenerative medicine. VII. SWOT Analysis Please list NetCord's top three Strengths: NetCord-FACT Standards. Education (online included. Global presence and exchange of information between CBBs. SWOT Analysis Please list NetCord's top three Weaknesses: Lack of visibility of the organization. NetCord does not represent all CBBs worldwide. NetCord does not give enough support to CBBs which are in the process of accreditation (stringent standards were developed but not enough help and support is given). SWOT Analysis Please list NetCord's top three Opportunities: 3

7 Greater development of continuing education opportunities for cord blood bank staff. More opportunities for CBBs and end-user transplant centers to meet and know each other. NetCord should be the organization which represent all CBBs (also the smaller ones) and coordinate more collaborations and solidarity between CBBs. SWOT Analysis Please list NetCord's top three Threats: Reimbursement for cord blood products (country specific). Frequency of other alternative transplantations (haplo) is increasing. Is there a need to further increase the CBU-inventory worldwide? NetCord has to face the evolution as it is going now: risk that big CBBs ship most of the CBUs and that smaller CBBs ship less (NetCord should help to improve this imbalance and should stimulate solidarity with the smaller CBBs with difficulties. 4

International NetCord Foundation Executive Committee Conference Call Minutes May 21, 2014

International NetCord Foundation Executive Committee Conference Call Minutes May 21, 2014 International NetCord Foundation Executive Committee Conference Call Minutes May 21, 2014 Committee Members: Staff: President Etienne Baudoux and Drs. Gesine Koegler, Joanne Kurtzberg, Alexander Platz

More information

International NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007

International NetCord Foundation Executive Committee Conference Call Minutes May 23, 2007 International NetCord Foundation Executive Committee Conference Call Minutes Committee Members: Board Members: Staff: President Joan Garcia and Drs. Yves Beguin and Elizabeth Shpall Drs. Cristina Navarrete

More information

Sponsors: Agenda. 2013 BioArchive Users Meeting. Liège, Belgium 23-24 May 2013

Sponsors: Agenda. 2013 BioArchive Users Meeting. Liège, Belgium 23-24 May 2013 2013 BioArchive Users Meeting Liège, Belgium 23-24 May 2013 Agenda Wednesday 22 May 1730 Arrival Ramada Plaza Hotel Liège Quai Saint-Léonard 36 4000 Liège Belgium 0032 (0)4 228 81 73 Thursday 23 May 0800

More information

Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy

Improving Quality in Cellular Therapy with FACT Accreditation. The Foundation for the Accreditation of Cellular Therapy Improving Quality in Cellular Therapy with FACT Accreditation The Foundation for the Accreditation of Cellular Therapy 1 Goals and Services of FACT Promote quality patient care and laboratory practice

More information

International NetCord Foundation Board of Directors Minutes November 21, 2006 Conference Call

International NetCord Foundation Board of Directors Minutes November 21, 2006 Conference Call International NetCord Foundation Board of Directors Minutes November 21, 2006 Conference Call Board Members: Staff: President Peter Wernet and Drs. Marcela Contreras, Joan Garcia, Eliane Gluckman, Paolo

More information

International NetCord Foundation Board of Directors Meeting - Monaco Minutes March 4, 2015

International NetCord Foundation Board of Directors Meeting - Monaco Minutes March 4, 2015 International NetCord Foundation Board of Directors Meeting - Monaco Minutes Board Members: Guests: Staff: President Etienne Baudoux and Drs. Heidi Elmoazzen, Ngaire Elwood, Anders Fasth, Eliane Gluckman,

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP

FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP WEDNESDAY 01/07/2015 Morning Parallel Sessions Cord Blood Banking Cellular Therapy/Regenerative Medicine

More information

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center (last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical

More information

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science,

Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Laura Machin, Lancaster Medical School, UK Takuya Matsushige, National Institute of Public Health, Japan Richard Williams, Management Science, Lancaster University, UK Today Exploring Perceptions of 'Quality'

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Do you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life Sciences @jessbiopharma

Do you have anything to add? If so, I d love to hear from you! Jessica Robinson Conference Manager Life Sciences @jessbiopharma 1 Who is the most influential figure in cord blood around the world? What is the biggest challenge to overcome in the use of cord blood as a source of stem cells? We asked 10 leading experts in the cord

More information

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and

More information

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries

More information

Sepax. your child s cord blood is in safe hands. World leader in adult stem cell processing

Sepax. your child s cord blood is in safe hands. World leader in adult stem cell processing Sepax your child s cord blood is in safe hands World leader in adult stem cell processing Biosafe Experience Credibility Innovation Dear Customer, Innovation in cell processing is our credo and this is

More information

Cord Blood Advisory Group: Organization and Highlights (from November 2013 meeting)

Cord Blood Advisory Group: Organization and Highlights (from November 2013 meeting) Cord Blood Advisory Group: Organization and Highlights (from November 2013 meeting) Presented to the AABB Center for Cellular Therapies Cord Blood subsection by Merry Duffy Director, Cord Blood Operations,

More information

cord blood saves lives...

cord blood saves lives... cord blood saves lives... ...by providing a rich source of blood stem cells that can be used to treat over 80 different diseases including leukemia, lymphoma, thalassemia, Tay-Sachs and sickle cell anemia.

More information

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION

More information

Cord Blood Bank Business Plan

Cord Blood Bank Business Plan Cord Blood Bank Business Plan A sample of how to create a new program Produced by the AABB subsection: Cellular Therapy Business Management with major contributions by Nicole Omer TABLE OF CONTENTS Page

More information

Cord Blood Bank Technology. E. Baudoux M. Duffy S. Querol L. Foeken. Survey Introduction

Cord Blood Bank Technology. E. Baudoux M. Duffy S. Querol L. Foeken. Survey Introduction Cord Blood Bank Technology E. Baudoux M. Duffy S. Querol L. Foeken Survey Introduction Preliminary considerations CB comparable to BM (Children) CB comparable to BM (Adults) Haplo identical transplants

More information

PACT Web Seminar July 19, 2007

PACT Web Seminar July 19, 2007 PACT Web Seminar July 19, 2007 Phyllis I. Warkentin, MD Professor, Pathology and Pediatrics University of NE Medical Center Medical Director Chairman, Accreditation Program Foundation for the Accreditation

More information

The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant

The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant Speech by Dr. Tsuneo A. Takahashi Translated by Stella Wang Japan and the United States are the two most experienced countries

More information

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation

More information

Search Coordinator Certificate

Search Coordinator Certificate Educational. Expert led. E learning. Information and registration Educational. Expert led. E learning. Professionals involved in unrelated adult donor/cord blood unit search and selection are essential

More information

5th Edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration. Summary of Changes

5th Edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration. Summary of Changes 5th Edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration Summary of Changes This document summarizes the changes made to the 5th edition of the

More information

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7 10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in

More information

Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status

Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Shelley Grant Branch Chief, Blood Stem Cell Transplantation Program September 11, 2015 Overview December 20, 2005 - HRSA began

More information

OneMatch National. Sue Smith, Executive Director, Stem Cells 2011-11- 04

OneMatch National. Sue Smith, Executive Director, Stem Cells 2011-11- 04 OneMatch National Public Cord Blood Bank Blood Matters 2011 Sue Smith, Executive Director, Stem Cells 2011-11- 04 No Disclosures To Declare The presenter does not have any involvement with the industry

More information

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases

EUROCORD. in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases ! 21%! EUROCORD 6756 cord blood transplantations performed from 1988 to March 2010 in 49 countries and 484 transplant centres* 264 EBMT 4847 (73%) cases 220 Non-EBMT 1797 (27%) cases * missing center

More information

The Danish Bone Marrow Donor Registry DBMDR

The Danish Bone Marrow Donor Registry DBMDR The DBMDR Vision To achieve and maintain a position as an internationally recognized hematopoietic stem cell donor registry with respect to high quality of donor data base and HLA typing, individualized,

More information

The Cord Blood Industry and Be The Match

The Cord Blood Industry and Be The Match The Cord Blood Industry and Be The Match Arthur Busse Manager of Business Analytics NMDP: Be The Match Sept. 11, 2015 Be The Match Mission Saving Lives with cellular therapy through science, service and

More information

Complete 2015-16 Global Cord Blood Banking Industry Report BIOINFORMANT WORLDWIDE, LLC

Complete 2015-16 Global Cord Blood Banking Industry Report BIOINFORMANT WORLDWIDE, LLC TABLE OF CONTENTS I. Abstract.. p.11 II. Overview of Technical & Medical Characteristics of Cord Blood..p.16 A. Introduction to Cord Blood and Cord Tissue B. Definitions and Nomenclature C. Technical Advantages

More information

Inspection Guide for WMDA reviewers

Inspection Guide for WMDA reviewers WMDA Review and Inspection of Unrelated Volunteer Donor and Umbilical Cord Blood Registries Providing Hematopoietic Progenitor Cell to International Patients for WMDA Accreditation Guidelines for Reviewers

More information

Cord Blood Banking in 2013. Sergio Querol, Barcelona CBB Merry Duffy, NMDP Lydia Foeken, WMDA Office

Cord Blood Banking in 2013. Sergio Querol, Barcelona CBB Merry Duffy, NMDP Lydia Foeken, WMDA Office Cord Blood Banking in 2013 Sergio Querol, Barcelona CBB Merry Duffy, NMDP Lydia Foeken, WMDA Office E-mail from Prof. Dr. G. Koegler: By the way: have you seen a drop of allogeneic CB provided worldwide

More information

So, get comfortable and enjoy finding out what the greatest achievements and challenges are facing the industry today.

So, get comfortable and enjoy finding out what the greatest achievements and challenges are facing the industry today. 1 Who is the most influential figure in cord blood around the world? What do you think has been the biggest achievement within the cord blood sector? Which is the most important development in cord blood

More information

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Health Resources and Services Administration. Advisory Council on Blood Stem Cell Transplantation

DEPARTMENT OF HEALTH AND HUMAN SERVICES. Health Resources and Services Administration. Advisory Council on Blood Stem Cell Transplantation This document is scheduled to be published in the Federal Register on 01/21/2016 and available online at http://federalregister.gov/a/2016-01127, and on FDsys.gov Billing Code 4165-15 DEPARTMENT OF HEALTH

More information

Program Report to the Advisory Council on Blood Stem Cell Transplantation. Shelley Grant September 11, 2015

Program Report to the Advisory Council on Blood Stem Cell Transplantation. Shelley Grant September 11, 2015 Program Report to the Advisory Council on Blood Stem Cell Transplantation Shelley Grant September 11, 2015 Presentation Overview Review legislative authority for Stem Cell Therapeutic and Research Reauthorization

More information

Vita 34 Parents Guide to umbilical Cord Blood Banking. secure first-class innovative

Vita 34 Parents Guide to umbilical Cord Blood Banking. secure first-class innovative Vita 34 Parents Guide to umbilical Cord Blood Banking secure first-class innovative Contents INTRODUCTION 3 THERAPEUTIC USES OF STEM CELLS 4 STEM CELLS IN CANCER TREATMENT STEM CELLS IN THE TREATMENT OF

More information

The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca

The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings. Prof. Tony Pagliuca The future of unrelated Stem Cell Transplant in the UK: DOH Working Party Findings Prof. Tony Pagliuca UK STEM CELL STRATEGIC FORUM The future of unrelated donor SCT in the UK Antonio Pagliuca, Transplant

More information

The donor search: the best donor or cord blood unit

The donor search: the best donor or cord blood unit The donor search: the best donor or cord blood unit Dr Bronwen Shaw Consultant in haematopoietic cell transplantation Royal Marsden Hospital /Anthony Nolan Overview Where do we find donors/units for transplantation

More information

Cord Blood Banking: worldwide overview

Cord Blood Banking: worldwide overview Cord Blood Banking: worldwide overview Joan García a MD PhD Public Public CB Banks mission To collect, store and supply CB units with the highest quality and safety To improve the probability of finding

More information

Asian Harmonization via Cord Blood Bank Network

Asian Harmonization via Cord Blood Bank Network Asian Harmonization via Cord Blood Bank Network Introduced by Shigetaka Asano Of Tokyo Cord Blood Bank SCA 200, Seoul Country China Indonesia Philippines Vietnam Japan Thailand Myanmar Korea Malaysia Cambodia

More information

FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP

FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP FACT WORKSHOP CORD BLOOD, CELLULAR THERAPY, REGENERATIVE MEDICINE INSPECTION AND ACCREDITATION WORKSHOP WEDNESDAY 01/07/2015 Morning Parallel Sessions Cord Blood Banking Cellular Therapy/Regenerative Medicine

More information

TABLE OF CONTENTS Complete 2015-16 Global Cord Blood Banking Industry Report (August 2015)

TABLE OF CONTENTS Complete 2015-16 Global Cord Blood Banking Industry Report (August 2015) TABLE OF CONTENTS Complete 2015-16 Global Cord Blood Banking Industry Report (August 2015) I. Abstract.. p.12 II. Overview of Technical & Medical Characteristics of Cord Blood..p.17 A. Introduction to

More information

What we will discuss today

What we will discuss today Umbilical cord blood banking It s Utility? Dr. Nita Radhakrishnan Pediatric Hematology Oncology Unit, Sir Ganga Ram Hospital, New Delhi What we will discuss today What are stem cells? What are the sources

More information

Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale

Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale Le norme internazionali NetCord-FACT: linee guida per la qualità nel bancaggio del sangue cordonale Topics 1- NetCord-FACT: l organizzazione internazionale ed il suo scopo 2- Le norme di qualità sul bancaggio

More information

Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014

Transmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014 FACT Accreditation for Cord Blood Banks and Cellular Therapy Nadim Mahmud, MD, PhD Associate Professor of Medicine Division of Hematology/Oncology Director, Hospital Stem Cell Laboratory Blood & Marrow

More information

Donation of Umbilical Cord Blood. A precious life offer. for everyone!

Donation of Umbilical Cord Blood. A precious life offer. for everyone! Donation of Umbilical Cord Blood A precious life offer for everyone! Donation of Umbilical Cord Blood A precious life offer for everyone! Page 3 Hellenic Cord Blood Bank Page 4 Haematopoietic Progenitor

More information

A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS

A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS A fact sheet UNRELATED BONE MARROW AND CORD BLOOD STEM CELL TRANSPLANTS Each year, thousands of patients are diagnosed with diseases treatable by a blood stem cell transplant. These blood stem cells can

More information

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE

STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE STEM CELLS FROM THE UMBLICAL CORD BLOOD AND UMBLICAL CORD TISSUE What are Stem Cells? Stem cells are the basic building blocks of all the cells, tissues and organs in the human body. The role of the stem

More information

Complete 2015-16 Global Cord Blood Banking Industry Report

Complete 2015-16 Global Cord Blood Banking Industry Report Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Cord Blood Banking Industry in subject line and your contact details. Executive Summary

More information

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012-2020

More information

CORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM

CORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM APPENDIX A SAMPLE CONSENT FORM CORD BLOOD TRANSPLANTATION (COBLT) STUDY SAMPLE CONSENT FORM FOR THE EXPANDED ACCESS PROTOCOL You (your child) are being asked to take part in a clinical research study.

More information

Umbilical Cord Blood Stem Cells Current Status & Future Potential

Umbilical Cord Blood Stem Cells Current Status & Future Potential Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu

More information

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.

hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge. hematopoietic stem cells from cord blood: - costless but too expensive? Dr. Vincent Kindler Geneva Cord Blood Bank HUG vincent.kindler@hcuge.ch Spring water: Manufactured by nature COSTLESS Cord Blood:

More information

Cord Blood Stem Cell Transplantation

Cord Blood Stem Cell Transplantation LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral

More information

UMBILICAL CORD BLOOD HARVESTING & STORAGE

UMBILICAL CORD BLOOD HARVESTING & STORAGE Protocol: TRP009 Effective Date: October 14, 2013 UMBILICAL CORD BLOOD HARVESTING & STORAGE Table of Contents Page COMMERCIAL, MEDICARE & MEDICAID COVERAGE RATIONALE... 1 BACKGROUND... 2 CLINICAL EVIDENCE...

More information

SAVE A LIFE... BY GIVING LIFE!

SAVE A LIFE... BY GIVING LIFE! SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the

More information

Cellular Therapy and Cord Blood Market Report 2013 Page 1. Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences

Cellular Therapy and Cord Blood Market Report 2013 Page 1. Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences Cellular Therapy and Cord Blood Market Report 2013 Kathy Gray Worldwide Market Reports & Consulting Coordinator Select Biosciences k.gray@selectbio.com Select Biosciences Market Reports Website: SelectBiosciences.com/marketreports/

More information

umbilical cord blood banking A guide for parents

umbilical cord blood banking A guide for parents umbilical cord blood banking A guide for parents 2 nd Edition 2016 This guide has been elaborated by the Council of Europe European Committee on Organ Transplantation (CD-P-TO). For more information, please

More information

Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations

Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations Summary of Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations Basic principles are established and the responsibilities of the national government are clarified in

More information

STEM CELL THERAPEUTIC OUTCOMES DATABASE

STEM CELL THERAPEUTIC OUTCOMES DATABASE C W Bill Young Cell Transplantation Program STEM CELL THERAPEUTIC OUTCOMES DATABASE BUS06_1ppt Stem Cell Therapeutic and Research Act of 2005 (PL 109-129) 129) Authorizing law, preceded by efforts to:

More information

Blood cells are vital to the human body

Blood cells are vital to the human body Candide FONT-SALA Blood cells are vital to the human body Red cells transport oxygen From http://www.english-online.at/biology/blood/blood-supply-and-blood-diseases.htm Red cell life span 120 days 200

More information

BMDW House Rules Date: April 5, 2013. Bone Marrow Donors Worldwide House Rules approval by the BMDW Editorial Board, April 5, 2013

BMDW House Rules Date: April 5, 2013. Bone Marrow Donors Worldwide House Rules approval by the BMDW Editorial Board, April 5, 2013 Bone Marrow Donors Worldwide House Rules approval by the BMDW Editorial Board, April 5, 2013 1. Definition Bone Marrow Donors Worldwide (BMDW) is an international service provided and managed by Europdonor

More information

S. 681 IN THE SENATE OF THE UNITED STATES

S. 681 IN THE SENATE OF THE UNITED STATES II TH CONGRESS 1ST SESSION S. 1 To amend the Public Health Service Act to establish a National Cord Blood Stem Cell Bank Network to prepare, store, and distribute human umbilical cord blood stem cells

More information

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape

Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape GENReports: Market & Tech Analysis Cord Blood for Cellular Therapy: A Snapshot of this Evolving Market Landscape > Enal Razvi, Ph.D. Biotechnology Analyst, Managing Director SELECTBIO US enal@selectbio.us

More information

No. 43/2007 The role of the state in establishing a public cord blood stem cell bank i

No. 43/2007 The role of the state in establishing a public cord blood stem cell bank i No. 43/2007 The role of the state in establishing a public cord blood stem cell bank i By Professor Vernon Louw MMed MBChB (Stell), Int.Med (Stell), Certified Clinical Haematologist (Leuven, Belgium) Associate

More information

Statement of Joanne Kurtzberg, M.D.

Statement of Joanne Kurtzberg, M.D. Statement of Joanne Kurtzberg, M.D. President of the Cord Blood Association Jerome Harris Distinguished Professor of Pediatrics and Pathology Chief Scientific Officer and Medical Director, Robertson Clinical

More information

IWK September 22, 2010. Cord Blood Program

IWK September 22, 2010. Cord Blood Program IWK September 22, 2010 Cord Blood Program Discussion Topics Insception s core values and core purpose Insception s experience Umbilical Cord Blood Stem cell Uses Insception Services in a Hospital Partnership

More information

CIGNA HEALTHCARE COVERAGE POSITION

CIGNA HEALTHCARE COVERAGE POSITION CIGNA HEALTHCARE COVERAGE POSITION Subject Umbilical Cord Blood Banking Table of Contents Coverage Position... 1 General Background... 1 Coding/Billing Information... 3 References... 3 Revised Date...

More information

OVERVIEW OF CURRENT STATUS OF STEM CELL TRANSPLANTATION IN VIETNAM

OVERVIEW OF CURRENT STATUS OF STEM CELL TRANSPLANTATION IN VIETNAM Ministry Of Health National Institute of Hematology and Blood Transfusion OVERVIEW OF CURRENT STATUS OF STEM CELL TRANSPLANTATION IN VIETNAM Prof. Nguyen Anh Tri MD., PhD., Director of NIHBT (Vietnam)

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_epithelial_ovarian_cancer 2/2001 11/2015 11/2016 11/2015 Description

More information

Fiscal Year 2013 Annual Progress Report on the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory Program

Fiscal Year 2013 Annual Progress Report on the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory Program U.S. Department of Health and Human Services Fiscal Year 2013 Annual Progress Report on the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory Program Executive Summary The

More information

Global Stem Cell Umbilical Cord Blood

Global Stem Cell Umbilical Cord Blood Report Code: DI 14114 Global Stem Cell Umbilical Cord Blood (product Types, Application, Technology, End Users and Geography) Global Share, Size, Industry Analysis, Trends, Opportunities, Growth and Forecast,

More information

A STRONG DECISION FOR A HEALTHY FUTURE

A STRONG DECISION FOR A HEALTHY FUTURE A STRONG DECISION FOR A HEALTHY FUTURE As parents, we always want to be sure we do everything for our children to help them build a strong and healthy future. At ovo biosurance we truly believe that cord

More information

UMBILICAL CORD BLOOD COLLECTION

UMBILICAL CORD BLOOD COLLECTION UMBILICAL CORD BLOOD COLLECTION by Frances Verter, PhD Founder & Director, Parent's Guide to Cord Blood Foundation info@parentsguidecordblood.org and Kim Petrella, RN Department of Obstetrics and Gynecology

More information

UMBILICAL CORD BLOOD BANKING A guide for parents

UMBILICAL CORD BLOOD BANKING A guide for parents UMBILICAL CORD BLOOD BANKING A guide for parents 2 nd EDITION INTRODUCTION The cells contained in the umbilical cord blood have therapeutic value for the treatment of blood disorders and immune diseases.

More information

Core Principles in Cellular Therapy, 3rd edition

Core Principles in Cellular Therapy, 3rd edition Brochure More information from http://www.researchandmarkets.com/reports/3146051/ Core Principles in Cellular Therapy, 3rd edition Description: This handy text provides a focused look at hematopoietic

More information

ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012

ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 ANTHONY NOLAN SEARCH ALGORITHM FOR A BASIC CORD BLOOD UNIT SELECTION BY SERGIO QUEROL AND IRINA EVSEEVA FEBRUARY 2012 PAGE 1 OF 7 PRINCIPLES FOR A NEW ALGORITHM Once cord blood transplantation (CBT) is

More information

06 LC 14 9480S A BILL TO BE ENTITLED AN ACT

06 LC 14 9480S A BILL TO BE ENTITLED AN ACT 0 LC 0S The House Committee on Health and Human Services offers the following substitute to SB : A BILL TO BE ENTITLED AN ACT 0 To amend Title of the Official Code of Georgia Annotated, relating to health,

More information

Donate your baby s cord blood and save lives.

Donate your baby s cord blood and save lives. Donate your baby s cord blood and save lives. A public nonprofit cord blood bank licensed by the FDA Each year, thousands of people are diagnosed with life-threatening diseases that may be cured with a

More information

CBS National Public Cord Blood Bank. Did you donate your cord blood?

CBS National Public Cord Blood Bank. Did you donate your cord blood? CBS National Public Cord Blood Bank Did you donate your cord blood? Tanya Petraszko MD FRCPC October 2014 Overview What is a stem cell? The importance of HLA Need for cord blood stem cells For all Canadians

More information

The Power & Potential of Cord Blood

The Power & Potential of Cord Blood The Power & Potential of Cord Blood Donna Regan, MT(ASCP)SBB, Director St. Louis Cord Blood Bank & Cellular Therapy Laboratory SSM Cardinal Glennon Children s Medical Center April 30, 2014 Objectives Since

More information

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood [Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,

More information

Cord Blood Market Trends, circa 2014

Cord Blood Market Trends, circa 2014 GENReports: Market & Tech Analysis Cord Blood Market Trends, circa 2014 > Enal Razvi, Ph.D. Managing Director Select Biosciences, Inc. enal@selectbio.us Topic Introduction and Scope The focus of this GEN

More information

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden

Public Cord Blood Tissue Bank Committee on Health Care Services and Representative Peaden HOUSE OF REPRESENTATIVES COMMITTEE ON HEALTH CARE SERVICES ANALYSIS BILL #: HB 2337 (PCB HCS 00-07) RELATING TO: SPONSOR(S): TIED BILL(S): Public Cord Blood Tissue Bank Committee on Health Care Services

More information

ADDITIONAL PROTOCOL TO THE CONVENTION ON HUMAN RIGHTS AND BIOMEDICINE CONCERNING TRANSPLANTATION OF ORGANS AND TISSUES OF HUMAN ORIGIN

ADDITIONAL PROTOCOL TO THE CONVENTION ON HUMAN RIGHTS AND BIOMEDICINE CONCERNING TRANSPLANTATION OF ORGANS AND TISSUES OF HUMAN ORIGIN European Treaty Series - No. 186 ADDITIONAL PROTOCOL TO THE CONVENTION ON HUMAN RIGHTS AND BIOMEDICINE CONCERNING TRANSPLANTATION OF ORGANS AND TISSUES OF HUMAN ORIGIN Strasbourg, 24.I.2002 Preamble The

More information

Umbilical Cord Blood Transplantation

Umbilical Cord Blood Transplantation Umbilical Cord Blood Transplantation V Rocha MD, PhD Hopital Saint Louis, Paris University 7 CIBMTR Milwaukee Umbilical Cord blood transplantation Background History Clinical results in children and adults

More information

Most up-to-date research on "Complete 2015-16 Global Cord Blood Banking Industry Report" to its huge collection of research reports.

Most up-to-date research on Complete 2015-16 Global Cord Blood Banking Industry Report to its huge collection of research reports. Most up-to-date research on "Complete 2015-16 Global Cord Blood Banking Industry Report" to its huge collection of research reports. The global cord blood banking industry has matured substantially over

More information

Hippocrates, Cords and Quality

Hippocrates, Cords and Quality Hippocrates, Cords and Quality Transfusion Medicine Resident Education Seminar April 3,2012 Renee Naiman, Director, Quality and Regulatory Affairs Overview -Brief update of cord blood history and usage.

More information

Directed/Related Cord Blood Collection by NHS Blood and Transplant

Directed/Related Cord Blood Collection by NHS Blood and Transplant Directed/Related Cord Blood Collection by Jacqui Thompson Clinical Scientist Section Head of Specialist Procedures Stem Cells and Immunotherapies Department National Blood Service, NHSBT Birmingham Why

More information

OUR JOURNEY THROUGH THE YEARS

OUR JOURNEY THROUGH THE YEARS The King Faisal Specialist Hospital and Research Centre Experience in Hematology, Oncology and Bone Marrow Transplantation OUR JOURNEY THROUGH THE YEARS REGGIE BELKHEDIM A Brief Overview: King Faisal Specialist

More information

How To Transplant Cord Blood

How To Transplant Cord Blood MP 7.01.38 Placental/Umbilical Cord Blood as a Source of Stem Cells Medical Policy Section Surgery Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013

More information

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose

Pr Eliane Gluckman, MD, FRCP, Disclosure of Interest: Nothing to Disclose Pr Eliane Gluckman, MD, FRCP, Hospital Saint Louis, University Paris- Diderot, France Should Haplo-identical transplantation be preferred to cord blood in patients without a matched donor? Disclosure of

More information

www.terrapinn.com/cordblood Top 10 global cord blood banks

www.terrapinn.com/cordblood Top 10 global cord blood banks Top 10 global cord blood banks The top 10 global cord blood banks Which cord blood banks around the world are the most influential and innovative? This is the question we asked ourselves as we began research

More information

1st Session 114 242 STEM CELL THERAPEUTIC AND RESEARCH REAUTHORIZATION ACT OF 2015

1st Session 114 242 STEM CELL THERAPEUTIC AND RESEARCH REAUTHORIZATION ACT OF 2015 114TH CONGRESS REPORT " HOUSE OF REPRESENTATIVES! 1st Session 114 242 STEM CELL THERAPEUTIC AND RESEARCH REAUTHORIZATION ACT OF 2015 SEPTEMBER 8, 2015. Committed to the Committee of the Whole House on

More information

Cigna Medical Coverage Policy

Cigna Medical Coverage Policy Cigna Medical Coverage Policy Subject Umbilical Cord Blood Banking Table of Contents Coverage Policy... 1 General Background... 1 Coding/Billing Information... 3 References... 4 Effective Date... 6/15/2014

More information

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the

More information

HRSA Update to the Advisory Council on Blood Stem Cell Transplantation. Shelley Grant September 15, 2014

HRSA Update to the Advisory Council on Blood Stem Cell Transplantation. Shelley Grant September 15, 2014 HRSA Update to the Advisory Council on Blood Stem Cell Transplantation Shelley Grant September 15, 2014 Presentation Overview Review legislative authority for Stem Cell Therapeutic and Research Reauthorization

More information